Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $150.03 | 4 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $74.63 | 2 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $60.00 | 1 | $0 (2019) |
| Becton, Dickinson and Company | $15.40 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $43.82 | 1 | AstraZeneca Pharmaceuticals LP ($43.82) |
| 2019 | $60.00 | 1 | E.R. Squibb & Sons, L.L.C. ($60.00) |
| 2018 | $30.81 | 1 | AstraZeneca Pharmaceuticals LP ($30.81) |
| 2017 | $15.40 | 1 | Becton, Dickinson and Company ($15.40) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/03/2020 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $43.82 | General |
| Category: Oncology | ||||||
| 03/18/2019 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $60.00 | General |
| 03/19/2018 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $30.81 | General |
| 06/29/2017 | Becton, Dickinson and Company | BD MAX (Device) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Molecular Diagnostics | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 39 | 4,201 | 4,670 | $545,676 | $125,416 |
| 2022 | 49 | 4,651 | 5,694 | $622,485 | $153,050 |
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87624 | Detection test by nucleic acid for human papillomavirus (hpv), high-risk types | Office | 2023 | 825 | 832 | $120,640 | $28,612 | 23.7% |
| 88175 | Pap test, automated thin layer preparation; automated system and manual rescreening | Office | 2023 | 1,029 | 1,047 | $125,640 | $27,306 | 21.7% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2023 | 207 | 278 | $41,700 | $9,560 | 22.9% |
| 87661 | Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique | Office | 2023 | 232 | 248 | $37,200 | $8,529 | 22.9% |
| 87511 | Detection test for gardnerella vaginalis (bacteria), amplified probe technique | Office | 2023 | 204 | 221 | $33,150 | $7,600 | 22.9% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 81 | 100 | $41,358 | $5,711 | 13.8% |
| 82670 | Measurement of total estradiol (hormone) | Office | 2023 | 129 | 176 | $16,368 | $4,819 | 29.4% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2023 | 66 | 133 | $19,950 | $4,574 | 22.9% |
| 87491 | Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique | Office | 2023 | 95 | 96 | $14,400 | $3,301 | 22.9% |
| 87591 | Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique | Office | 2023 | 95 | 96 | $14,400 | $3,301 | 22.9% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 87 | 114 | $9,804 | $2,883 | 29.4% |
| 83001 | Gonadotropin, follicle stimulating (reproductive hormone) level | Office | 2023 | 97 | 123 | $7,626 | $2,240 | 29.4% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 87 | 105 | $5,880 | $1,743 | 29.6% |
| 84402 | Testosterone (hormone) level, free | Office | 2023 | 43 | 60 | $5,100 | $1,498 | 29.4% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 13 | 17 | $5,185 | $1,353 | 26.1% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 136 | 160 | $4,800 | $1,266 | 26.4% |
| 84144 | Progesterone (reproductive hormone) level | Office | 2023 | 45 | 54 | $3,780 | $1,104 | 29.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 89 | 92 | $3,220 | $952.20 | 29.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 47 | 54 | $3,024 | $888.84 | 29.4% |
| 87529 | Detection test by nucleic acid for herpes simplex virus, amplified probe technique | Office | 2023 | 12 | 24 | $3,600 | $825.36 | 22.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 26 | 27 | $2,673 | $783.27 | 29.3% |
| 88141 | Pap test | Office | 2023 | 44 | 46 | $4,370 | $748.80 | 17.1% |
| 82627 | Dehydroepiandrosterone (dhea-s) hormone level | Office | 2023 | 27 | 33 | $2,442 | $719.07 | 29.4% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 66 | 79 | $2,907 | $669.87 | 23.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 80 | 88 | $2,728 | $669.68 | 24.5% |
About Dr. Sara Milchgrub, MD
Dr. Sara Milchgrub, MD is a Anatomic Pathology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699744144.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sara Milchgrub, MD has received a total of $150.03 in payments from pharmaceutical and medical device companies, with $43.82 received in 2020. These payments were reported across 4 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($150.03).
As a Medicare-enrolled provider, Milchgrub has provided services to 8,852 Medicare beneficiaries, totaling 10,364 services with total Medicare billing of $278,466. Data is available for 2 years (2022–2023), covering 88 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology
- Other Specialties Anatomic Pathology & Clinical Pathology
- Location Dallas, TX
- Active Since 03/16/2006
- Last Updated 09/13/2024
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- NPI Number 1699744144
Products in Payments
- IMFINZI (Drug) $43.82
- BD MAX (Device) $15.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology Doctors in Dallas
Dr. Olga Weinberg, M.d, M.D
Anatomic Pathology — Payments: $54,995
Dr. Kirthi Kumar, M.d., Ph.d, M.D., PH.D
Anatomic Pathology — Payments: $7,027
Richard Hopley, Md, MD
Anatomic Pathology — Payments: $5,797
Xin Zhou, Md, MD
Anatomic Pathology — Payments: $2,611
Elizabeth Dole, M.d, M.D
Anatomic Pathology — Payments: $779.72
Donna Lager, M.d, M.D
Anatomic Pathology — Payments: $581.91